

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 9.54733685 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.35600611 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 9.07157810 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.71605170 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.68491582 |
| 6 | glyoxylate metabolic process (GO:0046487) | 7.60300681 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 7.42659281 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.42515895 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.42515895 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.15897860 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.88892304 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 6.88892304 |
| 13 | * cellular glucuronidation (GO:0052695) | 6.70659258 |
| 14 | regulation of complement activation (GO:0030449) | 6.68133522 |
| 15 | drug metabolic process (GO:0017144) | 6.65487922 |
| 16 | urea metabolic process (GO:0019627) | 6.61878894 |
| 17 | * glucuronate metabolic process (GO:0019585) | 6.39929819 |
| 18 | * uronic acid metabolic process (GO:0006063) | 6.39929819 |
| 19 | ethanol oxidation (GO:0006069) | 6.29396941 |
| 20 | fibrinolysis (GO:0042730) | 6.06423020 |
| 21 | oxidative demethylation (GO:0070989) | 6.04877526 |
| 22 | bile acid biosynthetic process (GO:0006699) | 6.02268664 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 6.00151186 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.90003253 |
| 25 | protein carboxylation (GO:0018214) | 5.90003253 |
| 26 | negative regulation of sterol transport (GO:0032372) | 5.57749184 |
| 27 | negative regulation of cholesterol transport (GO:0032375) | 5.57749184 |
| 28 | bile acid metabolic process (GO:0008206) | 5.55525446 |
| 29 | urea cycle (GO:0000050) | 5.53401844 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 5.53219960 |
| 31 | phenylpropanoid metabolic process (GO:0009698) | 5.45422126 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 5.42027361 |
| 33 | blood coagulation, intrinsic pathway (GO:0007597) | 5.39860203 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.36835722 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.29340631 |
| 36 | bile acid and bile salt transport (GO:0015721) | 5.13139970 |
| 37 | ethanol metabolic process (GO:0006067) | 5.04815329 |
| 38 | regulation of plasminogen activation (GO:0010755) | 4.94370660 |
| 39 | glycine metabolic process (GO:0006544) | 4.86141811 |
| 40 | protein activation cascade (GO:0072376) | 4.78797424 |
| 41 | imidazole-containing compound metabolic process (GO:0052803) | 4.76348867 |
| 42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.75790114 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.67866745 |
| 44 | negative regulation of hemostasis (GO:1900047) | 4.63599317 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.63599317 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.51517208 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.51517208 |
| 48 | complement activation (GO:0006956) | 4.51257646 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.45171097 |
| 50 | opsonization (GO:0008228) | 4.43870953 |
| 51 | intestinal cholesterol absorption (GO:0030299) | 4.43271573 |
| 52 | complement activation, classical pathway (GO:0006958) | 4.41145722 |
| 53 | acute-phase response (GO:0006953) | 4.37900773 |
| 54 | daunorubicin metabolic process (GO:0044597) | 4.33395663 |
| 55 | polyketide metabolic process (GO:0030638) | 4.33395663 |
| 56 | doxorubicin metabolic process (GO:0044598) | 4.33395663 |
| 57 | glutamate metabolic process (GO:0006536) | 4.33350635 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.32264918 |
| 59 | phospholipid efflux (GO:0033700) | 4.30253162 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.30221662 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 4.28676013 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.23960166 |
| 63 | regulation of humoral immune response (GO:0002920) | 4.22182070 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.21050024 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.21050024 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.21050024 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 4.20115181 |
| 68 | cholesterol efflux (GO:0033344) | 4.19822340 |
| 69 | negative regulation of wound healing (GO:0061045) | 4.17116188 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.16838117 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.16838117 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.04657263 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.02762129 |
| 74 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.98268107 |
| 75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.94742849 |
| 76 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.94742849 |
| 77 | cytolysis (GO:0019835) | 3.92692574 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.88503081 |
| 79 | hormone catabolic process (GO:0042447) | 3.87594502 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.85541912 |
| 81 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.85299745 |
| 82 | tryptophan catabolic process (GO:0006569) | 3.84956906 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 3.84956906 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 3.84956906 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.82843514 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.79339008 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 3.78723976 |
| 88 | positive regulation of hemostasis (GO:1900048) | 3.78723976 |
| 89 | * flavonoid metabolic process (GO:0009812) | 3.78277726 |
| 90 | heme transport (GO:0015886) | 3.76372088 |
| 91 | reverse cholesterol transport (GO:0043691) | 3.76162426 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70362301 |
| 93 | arginine metabolic process (GO:0006525) | 3.68361705 |
| 94 | * xenobiotic metabolic process (GO:0006805) | 3.61372957 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 3.59777769 |
| 96 | primary alcohol catabolic process (GO:0034310) | 3.56590203 |
| 97 | ketone body metabolic process (GO:1902224) | 3.52861295 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.52372119 |
| 99 | positive regulation of coagulation (GO:0050820) | 3.51925755 |
| 100 | exogenous drug catabolic process (GO:0042738) | 10.3950275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.80054152 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75317790 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.73403882 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.60498297 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.34334482 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.62461508 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.56239120 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.15593547 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.84639148 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.28742751 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.45185371 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.17601703 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.15633338 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13030829 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2874124 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66056279 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63263379 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61712896 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44025187 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.40474473 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28071947 |
| 22 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23857476 |
| 23 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22692393 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19132747 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18726556 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15506652 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14097022 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09143008 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06759635 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05600224 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03519574 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99196434 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97964810 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95936907 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94695466 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86030972 |
| 37 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85165423 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82968975 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82583546 |
| 40 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80432039 |
| 41 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80275533 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79609640 |
| 43 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.77496305 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76643334 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76581794 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76452458 |
| 47 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76044430 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75401721 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74399713 |
| 50 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73423034 |
| 51 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71278292 |
| 52 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.70342130 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69504351 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68883226 |
| 55 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68875476 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.68699099 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 0.68577572 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67307991 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67170180 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.66560863 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.66186143 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66125157 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.64945117 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64293053 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.63728983 |
| 66 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62357639 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.61901166 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61665281 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.60725416 |
| 70 | NFYA_21822215_ChIP-Seq_K562_Human | 0.59849572 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.59810963 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59108089 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59048385 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57150922 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55718787 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55700559 |
| 77 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55391179 |
| 78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55310517 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55060574 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.54877320 |
| 81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54574255 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.53462968 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.53451025 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.52337569 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.52337569 |
| 86 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.51892327 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51586988 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51509887 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51476554 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.51178851 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.50047575 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49254135 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.49102686 |
| 94 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49009570 |
| 95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48756336 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48323266 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46713497 |
| 98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46689435 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46619107 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.46314273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.73436121 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.54574955 |
| 3 | MP0005365_abnormal_bile_salt | 6.00457647 |
| 4 | MP0005360_urolithiasis | 5.91730705 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.89083114 |
| 6 | MP0003195_calcinosis | 4.66375478 |
| 7 | MP0003252_abnormal_bile_duct | 4.31469804 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.81203036 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.62916259 |
| 10 | MP0003868_abnormal_feces_composition | 2.99724908 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.97812300 |
| 12 | MP0005332_abnormal_amino_acid | 2.46016947 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.44565845 |
| 14 | MP0009840_abnormal_foam_cell | 2.30123750 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.21351369 |
| 16 | MP0009697_abnormal_copulation | 2.19979529 |
| 17 | MP0000609_abnormal_liver_physiology | 1.93727572 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.89700213 |
| 19 | MP0005670_abnormal_white_adipose | 1.79121045 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.75825898 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.70770457 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.62370236 |
| 23 | MP0001764_abnormal_homeostasis | 1.47592027 |
| 24 | MP0005408_hypopigmentation | 1.28481930 |
| 25 | MP0009053_abnormal_anal_canal | 1.21609746 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.19677416 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.13774995 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10710767 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.09647949 |
| 30 | MP0001661_extended_life_span | 1.08037056 |
| 31 | MP0000598_abnormal_liver_morphology | 1.06963211 |
| 32 | MP0005451_abnormal_body_composition | 1.03631143 |
| 33 | MP0002132_abnormal_respiratory_system | 1.01662116 |
| 34 | MP0000604_amyloidosis | 0.99086988 |
| 35 | MP0009764_decreased_sensitivity_to | 0.89913984 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.88809061 |
| 37 | MP0009763_increased_sensitivity_to | 0.86492598 |
| 38 | MP0008469_abnormal_protein_level | 0.85338655 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.85188731 |
| 40 | MP0003186_abnormal_redox_activity | 0.84220594 |
| 41 | MP0002971_abnormal_brown_adipose | 0.80692169 |
| 42 | MP0003879_abnormal_hair_cell | 0.78417699 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.78248596 |
| 44 | MP0008872_abnormal_physiological_respon | 0.78079644 |
| 45 | MP0002282_abnormal_trachea_morphology | 0.75830727 |
| 46 | MP0001915_intracranial_hemorrhage | 0.75554740 |
| 47 | MP0005395_other_phenotype | 0.72070784 |
| 48 | MP0005464_abnormal_platelet_physiology | 0.69000528 |
| 49 | MP0003011_delayed_dark_adaptation | 0.68242561 |
| 50 | MP0005535_abnormal_body_temperature | 0.67766337 |
| 51 | MP0005023_abnormal_wound_healing | 0.67249686 |
| 52 | MP0002249_abnormal_larynx_morphology | 0.66621841 |
| 53 | MP0003690_abnormal_glial_cell | 0.64006283 |
| 54 | MP0005266_abnormal_metabolism | 0.63083630 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.61308943 |
| 56 | MP0002168_other_aberrant_phenotype | 0.56840100 |
| 57 | MP0003638_abnormal_response/metabolism_ | 0.56154715 |
| 58 | MP0000467_abnormal_esophagus_morphology | 0.55817528 |
| 59 | MP0005334_abnormal_fat_pad | 0.53316609 |
| 60 | MP0005187_abnormal_penis_morphology | 0.52270230 |
| 61 | MP0008874_decreased_physiological_sensi | 0.51366009 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.48888690 |
| 63 | MP0003329_amyloid_beta_deposits | 0.47984544 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.46847681 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.46144890 |
| 66 | MP0009785_altered_susceptibility_to | 0.42824682 |
| 67 | MP0003718_maternal_effect | 0.42641407 |
| 68 | MP0005166_decreased_susceptibility_to | 0.41556441 |
| 69 | MP0005448_abnormal_energy_balance | 0.40597532 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.38958313 |
| 71 | MP0000249_abnormal_blood_vessel | 0.37908888 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.37421229 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 0.37381590 |
| 74 | MP0000566_synostosis | 0.33968939 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.33932127 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.33778931 |
| 77 | MP0005164_abnormal_response_to | 0.32246758 |
| 78 | MP0003953_abnormal_hormone_level | 0.32039307 |
| 79 | MP0004130_abnormal_muscle_cell | 0.31937315 |
| 80 | MP0009115_abnormal_fat_cell | 0.31868895 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.29802343 |
| 82 | MP0003075_altered_response_to | 0.28042257 |
| 83 | MP0004883_abnormal_blood_vessel | 0.27712488 |
| 84 | MP0001756_abnormal_urination | 0.27497113 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.27317433 |
| 86 | MP0001851_eye_inflammation | 0.27247273 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.26106213 |
| 88 | MP0008873_increased_physiological_sensi | 0.23898537 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.23785852 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.23529069 |
| 91 | MP0001881_abnormal_mammary_gland | 0.22549087 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.19839855 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.19583028 |
| 94 | MP0003878_abnormal_ear_physiology | 0.19583028 |
| 95 | MP0005197_abnormal_uvea_morphology | 0.19241360 |
| 96 | MP0002970_abnormal_white_adipose | 0.19044618 |
| 97 | MP0002135_abnormal_kidney_morphology | 0.17430044 |
| 98 | MP0005409_darkened_coat_color | 0.17417966 |
| 99 | MP0005647_abnormal_sex_gland | 0.17363890 |
| 100 | MP0003959_abnormal_lean_body | 0.17063300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.92111330 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.15649823 |
| 3 | Complement deficiency (HP:0004431) | 9.06015052 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 8.46316907 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 8.42060199 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.09055671 |
| 7 | Abnormality of complement system (HP:0005339) | 7.38821506 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 7.16051827 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.95636828 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.92854952 |
| 11 | Joint hemorrhage (HP:0005261) | 5.75368607 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.51307595 |
| 13 | Xanthomatosis (HP:0000991) | 4.97385643 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.94844952 |
| 15 | Spontaneous abortion (HP:0005268) | 4.89429928 |
| 16 | Glomerulonephritis (HP:0000099) | 4.89194571 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.84968591 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.58038760 |
| 19 | Fat malabsorption (HP:0002630) | 4.32642610 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11925339 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.07571370 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.86408676 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82361286 |
| 24 | Nephritis (HP:0000123) | 3.78002613 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.58674921 |
| 26 | Steatorrhea (HP:0002570) | 3.35954722 |
| 27 | Hyperammonemia (HP:0001987) | 3.30892346 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.29634833 |
| 29 | Gingival bleeding (HP:0000225) | 3.25451123 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.22240932 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.04868417 |
| 32 | Hyperglycinemia (HP:0002154) | 3.02773663 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.98697405 |
| 34 | Rickets (HP:0002748) | 2.97473577 |
| 35 | Hyperbilirubinemia (HP:0002904) | 2.97397291 |
| 36 | Delayed CNS myelination (HP:0002188) | 2.95865099 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.90805598 |
| 38 | Osteomalacia (HP:0002749) | 2.87722687 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.79168473 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79168473 |
| 41 | Vascular calcification (HP:0004934) | 2.76072383 |
| 42 | Epidermoid cyst (HP:0200040) | 2.68506590 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66132846 |
| 44 | Thrombophlebitis (HP:0004418) | 2.64929048 |
| 45 | Mitral stenosis (HP:0001718) | 2.64231137 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61941084 |
| 47 | Abnormality of vitamin metabolism (HP:0100508) | 2.54247936 |
| 48 | Hyperglycinuria (HP:0003108) | 2.52818430 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.44504817 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.42402954 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.41233337 |
| 52 | Neonatal hypoglycemia (HP:0001998) | 2.40037634 |
| 53 | Hyperphosphaturia (HP:0003109) | 2.36370867 |
| 54 | Glycosuria (HP:0003076) | 2.24764868 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.24764868 |
| 56 | Fair hair (HP:0002286) | 2.23324269 |
| 57 | Elevated alkaline phosphatase (HP:0003155) | 2.18675524 |
| 58 | Metabolic acidosis (HP:0001942) | 2.16872609 |
| 59 | Purpura (HP:0000979) | 2.12885013 |
| 60 | Joint swelling (HP:0001386) | 2.10432407 |
| 61 | Menorrhagia (HP:0000132) | 2.07885126 |
| 62 | Poikilocytosis (HP:0004447) | 2.05937884 |
| 63 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.04638859 |
| 64 | Pulmonary embolism (HP:0002204) | 2.03389153 |
| 65 | Increased mean platelet volume (HP:0011877) | 2.02191022 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.01506764 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.01506764 |
| 68 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00446704 |
| 69 | Abnormal urine phosphate concentration (HP:0012599) | 1.99663379 |
| 70 | Cholelithiasis (HP:0001081) | 1.94909878 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 1.93514846 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 1.93412486 |
| 73 | Cerebral palsy (HP:0100021) | 1.89572492 |
| 74 | Ketosis (HP:0001946) | 1.87963529 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 1.87779626 |
| 76 | Myocardial infarction (HP:0001658) | 1.86972478 |
| 77 | Irritability (HP:0000737) | 1.82577450 |
| 78 | Abnormal platelet volume (HP:0011876) | 1.81755296 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 1.80272992 |
| 80 | Increased serum ferritin (HP:0003281) | 1.80073564 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 1.78175969 |
| 82 | Hypoglycemic coma (HP:0001325) | 1.77985355 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 1.77370268 |
| 84 | Enlarged kidneys (HP:0000105) | 1.76007373 |
| 85 | Neonatal onset (HP:0003623) | 1.73537891 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73115188 |
| 87 | Reticulocytosis (HP:0001923) | 1.73098609 |
| 88 | Gout (HP:0001997) | 1.70281268 |
| 89 | Acanthocytosis (HP:0001927) | 1.67206555 |
| 90 | Epistaxis (HP:0000421) | 1.66634363 |
| 91 | Skin nodule (HP:0200036) | 1.66598424 |
| 92 | Proximal tubulopathy (HP:0000114) | 1.63422488 |
| 93 | Bifid scrotum (HP:0000048) | 1.62663545 |
| 94 | Abnormal delivery (HP:0001787) | 1.60508402 |
| 95 | Amyloidosis (HP:0011034) | 1.59540403 |
| 96 | Arthropathy (HP:0003040) | 1.59287687 |
| 97 | Abnormal platelet function (HP:0011869) | 1.58315474 |
| 98 | Impaired platelet aggregation (HP:0003540) | 1.58315474 |
| 99 | Megaloblastic anemia (HP:0001889) | 1.57930181 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.56767335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.47083579 |
| 2 | MST1R | 3.64033519 |
| 3 | RIPK1 | 3.29601648 |
| 4 | PDK2 | 3.23164218 |
| 5 | FGFR4 | 3.17440059 |
| 6 | SIK1 | 2.75359495 |
| 7 | PIK3CG | 2.73892539 |
| 8 | TRIB3 | 2.42536875 |
| 9 | TYK2 | 2.38989468 |
| 10 | IRAK3 | 2.37901427 |
| 11 | MAP3K3 | 2.31505432 |
| 12 | ACVR1B | 2.21842982 |
| 13 | MAP3K12 | 2.12641548 |
| 14 | PRKACG | 1.91023457 |
| 15 | MAP3K2 | 1.89400619 |
| 16 | PIK3CA | 1.85638388 |
| 17 | PBK | 1.85340265 |
| 18 | MAPK11 | 1.81894590 |
| 19 | EPHA2 | 1.71617549 |
| 20 | PRKAA2 | 1.65301761 |
| 21 | EPHA3 | 1.55642296 |
| 22 | PDPK1 | 1.55447077 |
| 23 | MET | 1.51665353 |
| 24 | NTRK3 | 1.47057509 |
| 25 | MAP2K4 | 1.43293062 |
| 26 | TAOK3 | 1.41154369 |
| 27 | FGFR3 | 1.37352127 |
| 28 | TESK2 | 1.31809915 |
| 29 | BCKDK | 1.30710065 |
| 30 | MYLK | 1.28603794 |
| 31 | NEK9 | 1.28233590 |
| 32 | ABL2 | 1.23652615 |
| 33 | EPHB1 | 1.21129588 |
| 34 | FER | 1.19172994 |
| 35 | IGF1R | 1.13188667 |
| 36 | SMG1 | 1.12942855 |
| 37 | ERBB4 | 1.08278570 |
| 38 | NLK | 1.06427128 |
| 39 | TBK1 | 1.04281023 |
| 40 | JAK1 | 1.03879545 |
| 41 | PDK1 | 1.01357178 |
| 42 | ERBB2 | 1.01334593 |
| 43 | PRPF4B | 0.90315294 |
| 44 | PRKG2 | 0.86992532 |
| 45 | SCYL2 | 0.85608507 |
| 46 | PRKCZ | 0.85331611 |
| 47 | MAP3K1 | 0.84798967 |
| 48 | PRKCG | 0.84198632 |
| 49 | AKT3 | 0.80286269 |
| 50 | MAP3K6 | 0.80252227 |
| 51 | PTK6 | 0.77839564 |
| 52 | ICK | 0.76030298 |
| 53 | ARAF | 0.75639665 |
| 54 | PRKAA1 | 0.69360692 |
| 55 | PDGFRA | 0.69325108 |
| 56 | RET | 0.66255561 |
| 57 | EPHA4 | 0.65002538 |
| 58 | CAMK2G | 0.64953298 |
| 59 | PRKG1 | 0.64356502 |
| 60 | MAP2K6 | 0.61753346 |
| 61 | CSF1R | 0.60902308 |
| 62 | LMTK2 | 0.60670045 |
| 63 | PRKACA | 0.60383403 |
| 64 | MAP3K9 | 0.57948932 |
| 65 | CDK9 | 0.55607342 |
| 66 | PRKCA | 0.55430345 |
| 67 | KSR2 | 0.54549252 |
| 68 | STK38 | 0.51985019 |
| 69 | CAMKK2 | 0.50876606 |
| 70 | CDK6 | 0.50097348 |
| 71 | KDR | 0.50006743 |
| 72 | PTK2 | 0.49876484 |
| 73 | PRKACB | 0.49490927 |
| 74 | SGK3 | 0.49490306 |
| 75 | PRKCB | 0.49356523 |
| 76 | MAP2K2 | 0.49198595 |
| 77 | TNK2 | 0.46568990 |
| 78 | JAK2 | 0.45989044 |
| 79 | CSNK1E | 0.45920999 |
| 80 | MAP3K11 | 0.45237574 |
| 81 | CSNK1D | 0.45007718 |
| 82 | SRC | 0.44385390 |
| 83 | MAP3K5 | 0.44268602 |
| 84 | PINK1 | 0.43210311 |
| 85 | MAP3K13 | 0.40564672 |
| 86 | IRAK1 | 0.40519814 |
| 87 | DYRK1B | 0.39526395 |
| 88 | PRKCE | 0.38018370 |
| 89 | INSRR | 0.36918968 |
| 90 | RPS6KA3 | 0.36860271 |
| 91 | BRSK2 | 0.35927836 |
| 92 | PKN2 | 0.34443320 |
| 93 | LATS2 | 0.33628033 |
| 94 | MAPKAPK3 | 0.33530253 |
| 95 | RPS6KB2 | 0.33499725 |
| 96 | CSNK1A1 | 0.31394914 |
| 97 | TAOK2 | 0.31235307 |
| 98 | CAMK2B | 0.31062506 |
| 99 | GSK3A | 0.30917581 |
| 100 | CSNK2A1 | 0.30334907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.59501938 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.99578222 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85478271 |
| 4 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50858213 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.49850982 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.48846945 |
| 7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.38327136 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.98438990 |
| 9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.94702733 |
| 10 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.77165126 |
| 11 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.67992705 |
| 12 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.61045664 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59073719 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49509502 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40856859 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.35379638 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.16231879 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08330904 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96499963 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96329279 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92475628 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84843597 |
| 23 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.82514712 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.74464228 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64130169 |
| 26 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61011356 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57630782 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47779979 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40305207 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38114434 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37456159 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25332044 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.23438848 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22003980 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20952096 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17537980 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13403954 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13282714 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05764336 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05128009 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04089669 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.03160465 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03092525 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96463411 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93331551 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92139947 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89576861 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88529231 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84591536 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82947030 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.82094148 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81063114 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73838262 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60006793 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52745954 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47524856 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.43689348 |
| 58 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42841061 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38657340 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35069189 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34100071 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32320806 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30885906 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30071696 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29446862 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25548324 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22540315 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.21420860 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20788035 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.20355725 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16611170 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.16430712 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15791058 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15208516 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08769588 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.05722914 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04312709 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.02479641 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.02332627 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02302348 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.01798829 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2648013 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2575673 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2396811 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2308986 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2156759 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1836622 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1695445 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1682204 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1514798 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1319895 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1204300 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1088780 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0700416 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0574635 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0508695 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0491276 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0162997 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0080258 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0004883 |

